Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113528 | Critical Reviews in Oncology/Hematology | 2016 | 12 Pages |
Abstract
Better management of CID has the potential to reduce overall economic burden and improve patients' HRQoL. Available evidence also relays the need to conduct larger studies that assess HRQoL and consider cost beyond direct medical costs in order to understand the full impact of CID on HRQoL and healthcare resource utilization.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rosanna Tarricone, Dana Abu Koush, Barbara Nyanzi-Wakholi, Antonieta Medina-Lara,